J. Lee

发表

Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study

M. S. Lee, J. S. Lee, M. Yi, 1999, British Journal of Cancer.

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

L J Peters, J S Lee, S. Lippman, 1990, The New England journal of medicine.

The effect of 13-cis-retinoic acid chemoprevention on human serum retinol levels.

S. Lippman, W. Hong, H. Fritsche, 1998, Cancer detection and prevention.

Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers.

S. Lippman, J. Lee, J. Mulshine, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I trial of 9-cis retinoic acid in adults with solid tumors.

S. Lippman, J. Kurie, W. Hong, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium.

S. Lippman, J. Lee, R. Morice, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors.

S. Lippman, W. Hong, F. Fossella, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis.

S. Lippman, R. Lotan, W. Hong, 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Timing of radiotherapy in small cell lung cancer.

J. Lee, W. Hong, J. Lee, 1994, International journal of radiation oncology, biology, physics.

Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues.

R. Lotan, W. Hong, D. Shin, 1994, Cancer research.

Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.

S. Lippman, W. Hong, R. Newman, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Determination of biomarkers for intermediate end points in chemoprevention trials.

S. Lippman, R. Lotan, W. Hong, 1992, Cancer research.

Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials

S. Lippman, W. Hong, W. Hittelman, 1992, Journal of cellular biochemistry. Supplement.

The incidence of second primary tumors in long-term survivors of small-cell lung cancer.

S. Lippman, J. Lee, J. Lee, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biomarkers as intermediate end points in chemoprevention trials.

R. Lotan, W. Hong, W. Hittelman, 1990, Journal of the National Cancer Institute.

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin-naive patients with extensive-disease small cell lung cancer (Cancer (2009) 116, (132-136))

Dong Han Lee, M. Ahn, C. Suh, 2010 .

Phase I trial of oral green tea extract in adult patients with solid tumors.

F. Khuri, K. Pisters, D. Shin, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.

R. Komaki, W. Sause, B. Emami, 1998, International journal of radiation oncology, biology, physics.

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy.

R. A. Robinson, S. Lippman, J. Lee, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of epidermal growth factor receptor, polyamine levels, ornithine decarboxylase activity, micronuclei, and transglutaminase I in a 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model.

T. Slaga, R. Lotan, W. Hong, 1990, Cancer research.

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer.

J. Yook, B. Kim, J. Ahn, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results.

F. Khuri, C. Stevens, R. Komaki, 2002, Seminars in radiation oncology.

Long-term impact of smoking on lung epithelial proliferation in current and former smokers.

F. Khuri, J. Lee, R. Morice, 2001, Journal of the National Cancer Institute.

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.

M. Ahn, E. Choi, S-H. Jung, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III trial of concurrent thoracic radiotherapy with either fi rst-or third-cycle chemotherapy for limited-disease small-cell lung cancer †

M. Ahn, E. Choi, S-H. Jung, 2013 .

A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer.

B. Nam, H. Kim, J. Lee, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.

S. Lippman, R. Lotan, W. Hong, 1996, Cancer research.

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation.

Dae-Ho Lee, C. Suh, H. T. Kim, 2012, Lung Cancer.

Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer.

S. Lippman, F. Khuri, R. Lotan, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors in lung cancer.

J. Lee, W. Hong, 1992, The New England journal of medicine.

Management strategies for recurrent non-small cell lung cancer.

F. Fossella, J. Lee, W. Hong, 1997, Seminars in oncology.

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

S. Lippman, J. Lee, R. Morice, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of adjuvant surgery in the combined modality therapy of small-cell bronchogenic carcinoma after a chemotherapy-induced partial remission.

C. Mountain, M. Valdivieso, D. Carr, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.

R. Lotan, W. Hong, J. Lee, 1997, Journal of the National Cancer Institute.

Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.

F. Fossella, J. Bérille, J. Lee, 1995, Seminars in oncology.

Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410)

W. Curran, R. Komaki, S. Hauser, 2000 .

Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion.

S. Lippman, W. Hong, W. Hittelman, 1993, Journal of the National Cancer Institute.

A Randomized Double‐Blind Trial of Ondansetron Alone Versus in Combination with Dexamethasone Versus in Combination with Dexamethasone and Lorazepam in the Prevention of Emesis Due to Cisplatin‐Based Chemotherapy

M. Ahn, C. Suh, Jung Shin Lee, 1994, American journal of clinical oncology.

Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.

W. Hong, R. Perez-soler, F. Fossella, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

S. Lippman, J. Lee, W. Hong, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.

W. Hong, W. Hittelman, D. Shin, 1993, Journal of the National Cancer Institute.

Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells.

R. Lotan, W. Hong, P. Steck, 1992, Journal of the National Cancer Institute. Monographs.

Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression.

S. Lippman, R. Lotan, W. Hong, 1995, Cancer research.

Genetic analysis of second primary lung cancers in patients surviving small cell lung cancer.

E. Shaw, M. Tucker, M. Kelley, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase II study of paclitaxel and capecitabine combination chemotherapy in patients with advanced gastric cancer as a first-line therapy

J. Yook, M. Ryu, B. Kim, 2004 .

Combination of 5‐Fluorouracil and Recombinant Interferon α‐2B in Advanced Gastric Cancer: A Phase I Study

Y. S. Lee, S. H. Ahn, K. H. Lee, 1992, American journal of clinical oncology.

Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852.

R. Perez-soler, N. Donato, D. Shin, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer.

J. Minna, W. Hong, L. Mao, 1997, Cancer research.

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.

S. Lippman, W. Hong, H. Libshitz, 1992, Journal of the National Cancer Institute.

Analysis of the epidermal growth factor receptor gene in fresh human head and neck tumors.

A. Eisbruch, J. Gutterman, J. Lee, 1987, Cancer research.

Reduction to homozygosity at the SIS/PDGF-2 locus in human mesenchymal tumors.

W. Hong, R. Ferrell, D. Shin, 1988, Biochemical and biophysical research communications.

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.

F. Khuri, W. Hong, J. Roth, 1999, Journal of the National Cancer Institute.

Phase II Pilot Study with Cisplatin, Etoposide, and Continuous‐Infusion 5‐Fluorouracil in Metastatic Non‐small Cell Lung Cancer

W. Murphy, J. Lee, P. Holoye, 1987, American journal of clinical oncology.

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

J. Roth, R. Komaki, E. Atkinson, 1994, Journal of the National Cancer Institute.

Early genetic changes during upper aerodigestive tract tumorigenesis

W. Hong, W. Hittelman, D. Shin, 1993, Journal of cellular biochemistry. Supplement.

A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer.

W. Hong, R. Komaki, W. Hittelman, 1999, Seminars in radiation oncology.

Evidence of malignant features in histologically mature teratoma.

C. Logothetis, R. Amato, J. Ro, 1991, The Journal of urology.

Primary chemotherapy of brain metastasis in small-cell lung cancer.

W. Murphy, B. Glisson, J. Lee, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study.

R. Govindan, Keunchil Park, S. Peters, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Predicting cancer development in oral leukoplakia: ten years of translational research.

S. Lippman, R. Lotan, J. Lee, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis.

W. Hong, W. Hittelman, D. Shin, 1993, Cancer research.

Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer.

A. Sahin, B. Brown, W. Hittelman, 1991, The New England journal of medicine.

Mucinous adenocarcinoma of the prostate with endobronchial metastasis.

A. Sahin, J. Ro, A. Ayala, 1990, American journal of clinical pathology.

Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04.

D. Ettinger, R. Komaki, W. Sause, 2002, International journal of radiation oncology, biology, physics.

Clonal genetic alterations in the lungs of current and former smokers.

J S Lee, S. Lippman, F. Khuri, 1997, Journal of the National Cancer Institute.

Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.

F. Khuri, W. Hong, L. Mao, 1999, Cancer research.

Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. Mapping genotype/phenotype heterogeneity.

W. Hittelman, J. Ro, S. Y. Kim, 1993, The American journal of pathology.

Neurotoxicity in long-term survivors of small cell lung cancer.

M. Valdivieso, H. Barkley, W. Murphy, 1986, International journal of radiation oncology, biology, physics.

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.

S. Lippman, R. Perez-soler, F. Fossella, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice.

R. Perez-soler, H. Yee, L. Mao, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma.

D. Nyberg, R. Perez-soler, J. Kurie, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Implantation metastasis of carcinoma after percutaneous fine-needle aspiration biopsy.

D. Shin, I. Dimery, R. Dekmezian, 1992, Chest.

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

M. Kris, D. Gandara, E. Vokes, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.

J. Lee, W. Hong, J. Greenberg, 1992, Seminars in oncology.

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.

S Lippman, S. Lippman, R. Perez-soler, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer.

M. Socinski, K. Rowland, R. Lilenbaum, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report.

R. Komaki, J. Cox, F. Fossella, 1998, International journal of radiation oncology, biology, physics.

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06.

W. Curran, S. McDonald, R. Komaki, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.

J. Lee, W. Hittelman, J. Ro, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic non-myeloablative stem cell transplantation for the patients with heavily pre-treated refractory lymphoma.

Y. Kang, K. H. Lee, J. Lee, 2001, Haematologica.

Spontaneous remission of aplastic anemia: a retrospective analysis.

H. Chi, K. H. Lee, J. Lee, 2001, Haematologica.

Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations.

R. Rosell, M. Monzó, Cristina Martín, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumors.

S. Lippman, W. Hong, F. Fossella, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Squamous metaplasia of the bronchial mucosa and its relationship to smoking.

S Lippman, S. Lippman, R. Morice, 1993, Chest.

ZD1839 (Iressa) in non-small-cell lung cancer.

F. Khuri, R. Herbst, K. Pisters, 2002, Clinical lung cancer.

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.

S. Lippman, F. Fossella, D. Shin, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04.

D. Ettinger, W. Curran, P. Rubin, 1997, International journal of radiation oncology, biology, physics.

Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancer.

D. Carr, W. Murphy, J. Lee, 1987, Cancer treatment reports.

The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies.

W. Sause, B. Movsas, J. Cox, 1999, International journal of radiation oncology, biology, physics.

Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation.

K. H. Lee, J. Lee, S. Kim, 2001, Leukemia research.

Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings.

H. Chi, K. H. Lee, J. Lee, 2001, Haematologica.

Visualization of the timing of gene amplification during multistep head and neck tumorigenesis.

W. Hong, M. Tainsky, W. Hittelman, 2000, Cancer research.

Chemoprevention of lung cancer.

J. Lee, W. Hong, M. Huber, 1993, Seminars in oncology.

Modulation by 13-cis retinoic acid of biologic markers as indicators of intermediate endpoints in human oral carcinogenesis.

R. Weber, S. Lippman, R. Lotan, 1990, Progress in clinical and biological research.

Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.

R. Komaki, R. Perez-soler, J. Kurie, 1998, International journal of radiation oncology, biology, physics.

Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers.

F. Khuri, W. Franklin, R. Morice, 1998, Journal of the National Cancer Institute.

The management of superior sulcus tumors.

R. Komaki, J. Cox, J. Putnam, 2000, Seminars in surgical oncology.

Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center.

J. Roth, R. Komaki, J. Cox, 2000, International journal of radiation oncology, biology, physics.

Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.

R. Komaki, B. Emami, J. Cox, 1997, American journal of clinical oncology.

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.

W. Sause, J. Cox, R. Komaki, 2000, International journal of radiation oncology, biology, physics.

Timing of elective brain irradiation: a critical factor for brain metastasis-free survival in small cell lung cancer.

M. Valdivieso, H. Barkley, W. Murphy, 1987, International journal of radiation oncology, biology, physics.

Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

J. Roth, R. Komaki, E. Atkinson, 1998, Lung cancer.

A phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumors

J. Desai, K. Rau, M. Friedlander, 2018, Annals of Oncology.

425PDClinical activity and safety of the EGFR mutant-specific inhibitor, BI1482694, in patients (pts) with T790M-positive NSCLC

Y. Min, Ju Sun Kim, K. Lee, 2015 .

Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up.

S. Lippman, J. Lee, W. Hong, 1997, Journal of the National Cancer Institute.

Chromosome polysomy and histological characteristics in oral premalignant lesions.

S. Lippman, W. Hong, W. Hittelman, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Phase II trial evaluating imatinib (I) in patients (pts) with anaplastic thyroid carcinoma (ATC).

T. Giordano, F. Worden, J. Sisson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Novel approaches to locally advanced unresectable non-small cell lung cancer.

C. Stevens, R. Komaki, J. Cox, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary report.

F. Khuri, R. Komaki, K. Pisters, 1997, Seminars in oncology.

Effects of brain irradiation and chemotherapy on myelosuppression in small-cell lung cancer.

H. Barkley, W. Murphy, J. Lee, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

LBA6_PROsimertinib vs standard of care (SoC) EGFR-TKI as first-line treatment in patients with EGFR-TKI sensitising mutation (EGFRm) positive advanced non-small cell lung cancer (NSCLC): FLAURA Asian subset

Ying Cheng, Y. Ohe, B. Chewaskulyong, 2017 .

Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.

S. Kim, Y. S. Lee, K. H. Lee, 1996, Journal of Korean medical science.

Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis.

K. H. Lee, J. Lee, S. Kim, 1994, Journal of Korean medical science.